Location: Home
  • search
  • go
  • Relate News
  • 7/2/2021CDE Solicits Comments on the Requirements for Pharmaceutical Research ...
  • 7/2/2021CDE Solicits Comments on the Guidelines for Clinical Value-Oriented Cl...
  • 7/2/2021CDE Solicits Comments on the Guidelines for Clinical Studies of Crohn'...
  • 7/1/2021ArriVent Raises $150M to Bring Chinese Drugs to Western Markets
  • 6/30/2021BeiGene Wins Approval for $31B IPO at Shanghai's STAR Market
  • 6/30/2021HUTCHMED Launches $325M Initial Public Offering in Hong Kong
  • 6/30/2021Chinese Biotech/Healthcare Listings Help Elevate HK IPO Market To Thir...
  • 6/30/2021NHSA Issues the Working Plan and the Application Guide for Adjustment ...
  • 6/30/2021Recent Executive Moves
  • 6/30/2021IQVIA: Potential of Chinese Pharma Lies in the Country's Huge Patient ...
  • 6/30/2021IQVIA: Chinese Retail Pharmacy Sales Down 1.4% in Q1/2021
  • 6/30/2021Review of Drug Approvals under the Priority Review and Breakthrough Pa...
  • 6/30/2021Listed Domestic Pharma Cos See Sharp Performance Growth in Q1
  • 6/30/2021Chinese Enteral Nutrition Market Predicted to Rise 2021-2025 and Beyon...
  • 6/30/2021Financial-related Company News in Brief
  • 6/30/2021China Further Deepens Healthcare Reform with A New Wave of Initiatives...
  • 6/29/2021Innovent Granted Chinese Approval of TYVYT in Combo with BYVASDA as...
  • 6/29/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (46...
  • 6/29/2021Vivoryon and Simcere Announce Licensing Deal for N3pE Amyloid-targetin...
  • 6/28/2021China Issues the Medium- and Long-Range Development Plan for Medical I...
  • 6/28/2021NHC Issues the Management Parameters for Rationalized Clinical Applica...
  • 6/28/2021WuXi STA Plans Pharmaceutical Chemical Facility in Delaware
  • 6/28/2021InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib b...
  • 6/28/2021J&J Partner Legend Plans JV Facility in Belgium as Its CAR-T Cilta-cel...
  • 6/28/2021Innovent Announces License Agreement with Synaffix in an ADC Technolog...
  • 6/28/2021Lonza Invests in Facility in China
  • 6/28/2021Junshi Biosciences Announces NMPA Acceptance of IND Application for JS...
  • 6/28/2021PharmaDJ's China Biotech Fundraising Tracker: April 2021
  • 6/28/2021Latest Developments on Data Supplementation for Chemical or Pharmaceut...
  • 6/25/2021AZ's Pulmicort, Bayer's Xarelto Among Big Losers in China's Largest Ro...
  • Page:125/719 Total number of articles:21549: [First][<<] [123] [124] [125] [126] [127] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group